Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Toxicol Rep. 2014 Jan 1;1:820–833. doi: 10.1016/j.toxrep.2014.09.010

Table I.

Effect of PCB126 and PCB153 on the organ and tissue weight.

Group/ Implants Duration of study (days) Body wt. (g) Liver (mg/g bw) Lung (mg/g bw) Kidney (g) Thymus (mg) Ovary (mg) Mammary (g)
Untreated control 15 179 ± 3.6 42.6 ± 1.2 6.0 ± 0.3 1.4 ± 0.1 359 ± 6 111 ± 9 3.1 ± 0.3
Sham Implants 15 178 ± 10.4 40.9 ± 0.8 6.4 ± 1.0 1.4 ± 0.1 323 ± 2 112 ± 16 3.5 ± 0.2
PCB 153 15 181 ± 11.7 40.5 ± 3.5 5.8 ± 0.5 1.4 ± 0.1 358 ± 3 128 ± 17 3.8 ± 0.6
PCB 126 15 177 ± 4.8 *55.2 ± 4.4 8.2 ± 2.4 1.3 ± 0.1 *222 ± 3 93 ± 16 2.9 ± 0.6
PCB126 + PCB153 6 156 ± 3.9 *53.2 ± 4.4 6.5 ± 0.5 1.3 ± 0.2 ***270 ± 3 80 ± 13 2.6 ± 0.2
PCB126 + PCB153 15 169 ± 5.9 *57.9 ± 3.4 7.7 ± 1.5 1.4 ± 0.2 ***248 ± 6 93 ± 14 3.0 ± 0.2
PCB126 + PCB153 45 213 ± 7.3 *48.3 ± 2.5 6.6 ± 0.4 1.5 ± 0.1 ***110 ± 1 105 ± 9 3.5 ± 0.7
*

p < 0.05, significantly different from the 15 day untreated control, animals.

***

p ± 0.001. Data shown is average ± SD of four significantly different from the 15 day untreated control, animals.